Experience with Oesophageal Cancer: A Ten-Year Single Centre Study Reflecting Daily Practice

• Published in: ISRN Gastroenterology Vol. 2013; pp. 205417 - 5
• Main Authors: Loffeld, R. J. L. F., Dekkers, P. E. P.
• Format: Journal Article
• Language: English
• Published: Egypt Hindawi Publishing Corporation 2013; Hindawi Limited
• Subjects: Cancer; Cancer therapies; Clinical Study; Comorbidity; Hospitals; Medical treatment; Mortality; Patients; Radiation therapy; Surgery; Survival analysis; Tumors
• ISSN: 2090-4398; 2090-4401; 2090-4401
• DOI: 10.1155/2013/205417

Introduction. Studied patients with oesophageal cancer do not represent normal daily presentation. Aim. A retrospective study was done in all consecutive patients in order to describe presentation, treatment, and survival. Patients. All patients in a ten-year period were included. Patients were grouped in three groups. Group 1: no metastases and potentially curable, dead, or alive at time of evaluation. Group 2: patients presenting with metastases and treated with palliative chemotherapy, and group 3: patients with or without metastases but untreatable because of low Karnofsky index or important comorbidity rendering treatment not feasible. Results. One hundred thirty one evaluable patients were included. There was no difference in histological type of the tumour. Patients in group 3 were significantly older. Survival was not different between groups 2 and 3. Survival in group 1 was significantly longer (P<0.0001) compared with groups 2 and 3. Patients in group 1 received treatment with chemoradiation and surgery. Patients in groups 2 and 3 were more often treated with palliative chemotherapy and endoscopic stenting. Conclusion. The overall survival of oesophageal cancer in normal daily life is poor. Supportive care seems to be the best treatment option in patients with metastases or low Karnofsky index. Palliative chemotherapy does not add to overall survival.